Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Melanoma

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 27 articles: HTML format

Single Articles

January 2008
1. SHARMA R , Kacevska M, London R, Clarke SJ, et al
   Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies.
   Br J Cancer. 2008;98:91-7.
   PubMed     Related articles    Abstract available
   
   
   December 2007
2. FRANCO-LIE I , Iversen T, Robsahm TE, Abdelnoor M, et al
   Birth weight and melanoma risk: a population-based case-control study.
   Br J Cancer. 2007;.
   PubMed     Related articles    Abstract available
   
   
   November 2007
3. THIES A , Dautel P, Meyer A, Pfuller U, et al
   Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model.
   Br J Cancer. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
4. MHAIDAT NM , Zhang XD, Allen J, Avery-Kiejda KA, et al
   Temozolomide induces senescence but not apoptosis in human melanoma cells.
   Br J Cancer. 2007;97:1225-33.
   PubMed     Related articles    Abstract available   Free Full Text
   
   
   October 2007
5. ATZPODIEN J , Terfloth K, Fluck M, Reitz M, et al
   Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients.
   Br J Cancer. 2007;.
   PubMed     Related articles    Abstract available
   
   
   June 2007
6. PRITCHARD-JONES RO , Dunn DB, Qiu Y, Varey AH, et al
   Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma.
   Br J Cancer. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
7. FOJTOVA M , Boudny V, Kovarik A, Lauerova L, et al
   Development of IFN-gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells.
   Br J Cancer. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
8. POLAK ME , Borthwick NJ, Gabriel FG, Johnson P, et al
   Mechanisms of local immunosuppression in cutaneous melanoma.
   Br J Cancer. 2007;96:1879-87.
   PubMed     Related articles    Abstract available
   
   
   
9. MACKIE RM , Bray C, Vestey J, Doherty V, et al
   Melanoma incidence and mortality in Scotland 1979-2003.
   Br J Cancer. 2007;96:1772-7.
   PubMed     Related articles    Abstract available
   
   
   
10. ALSTON RD , Rowan S, Eden TO, Moran A, et al
    Cancer incidence patterns by region and socioeconomic deprivation in teenagers and young adults in England.
    Br J Cancer. 2007;96:1760-6.
    PubMed     Related articles    Abstract available
    
    
    March 2007
11. FEDER-MENGUS C , Ghosh S, Weber WP, Wyler S, et al
    Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
12. LICKLITER JD , Cox J, McCarron J, Martinez NR, et al
    Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.
    Br J Cancer. 2007;96:600-8.
    PubMed     Related articles    Abstract available
    
    
    
13. FORGET MA , Turcotte S, Beauseigle D, Godin-Ethier J, et al
    The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types.
    Br J Cancer. 2007;96:646-53.
    PubMed     Related articles    Abstract available
    
    
    
14. MOWBRAY M , Stockton DL, Doherty VR
    Changes in the site distribution of malignant melanoma in South East Scotland (1979-2002).
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
15. THIES A , Mauer S, Fodstad O, Schumacher U, et al
    Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
16. SMALLEY KS , Contractor R, Haass NK, Lee JT, et al
    Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
17. KORBELIK M , Cooper PD
    Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulin.
    Br J Cancer. 2007;96:67-72.
    PubMed     Related articles    Abstract available
    
    
    December 2006
18. LARKIN JM , Hughes SA, Beirne DA, Patel PM, et al
    A Phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
19. MILLWARD MJ , House C, Bowtell D, Webster L, et al
    The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    August 2006
20. GRAY-SCHOPFER VC , Cheong SC, Chong H, Chow J, et al
    Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
21. EISEN T , Ahmad T, Flaherty KT, Gore M, et al
    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    July 2006
22. GOTTLIEB DJ , Li YC, Lionello I, Tanzarella S, et al
    Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    June 2006
23. LU F , Dai DL, Martinka M, Ho V, et al
    Nuclear ING2 expression is reduced in human cutaneous melanomas.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
24. DOWNING A , Newton-Bishop JA, Forman D
    Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    May 2006
25. STREIT S , Mestel DS, Schmidt M, Ullrich A, et al
    FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
26. FONTIJN D , Duyndam MC, van Berkel MP, Yuana Y, et al
    CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    April 2006
27. LAU YS , Sabokbar A, Giele H, Cerundolo V, et al
    Malignant melanoma and bone resorption.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: